SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-002378
Filing Date
2015-08-10
Accepted
2015-08-10 17:16:04
Documents
3
Period of Report
2015-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_080515.htm 8-K 27798
2 PRESS RELEASE ex99-1.htm EX-99.1 15969
3 GRAPHIC ohr-logo.jpg GRAPHIC 8189
  Complete submission text file 0001387131-15-002378.txt   56636
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 151041738
SIC: 2834 Pharmaceutical Preparations